OncoCyte (OCX) Stock Chart & Stock Price History → What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (From Weiss Ratings) (Ad) Free OCX Stock Alerts $2.74 +0.09 (+3.40%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends OncoCyte Stock Price Performance5 Day Performance+1.86%1 Month Performance-1.42%3 Month Performance-8.67%6 Month Performance-29.38%Year-To-Date Performance+9.60%1 Year Performance-37.61% Receive OCX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsWhat is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners”A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.”Click here to find out who they are. OCX Stock Chart for Sunday, June, 2, 2024 OCX Chart by TradingView OncoCyte Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$2.65$2.74+3.40%$2.95$2.7140,524 shs$22.66 million05/30/2024$2.62$2.65+1.15%$2.81$2.608,520 shs$21.92 million05/29/2024$2.69$2.62-2.60%$2.69$2.5614,436 shs$21.67 million05/28/2024$2.83$2.69-4.95%$2.84$2.6512,543 shs$22.25 million05/27/2024$2.83$2.83$2.86$2.714,600 shs$23.40 million05/24/2024$2.80$2.83+1.07%$2.86$2.714,627 shs$23.40 million Get the Latest News and Ratings for OCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$2.91$2.80-3.78%$2.90$2.793,273 shs$23.16 million05/22/2024$2.82$2.91+3.19%$2.91$2.732,334 shs$24.07 million05/21/2024$2.76$2.82+2.17%$2.98$2.7128,786 shs$23.32 million05/20/2024$2.93$2.76-5.80%$2.99$2.7419,615 shs$22.83 million05/17/2024$3.05$2.93-3.93%$3.08$2.9232,016 shs$24.23 million05/16/2024$2.89$3.05+5.54%$3.09$2.70104,949 shs$25.22 million05/15/2024$2.90$2.89-0.34%$2.98$2.8032,402 shs$23.90 million05/14/2024$2.88$2.90+0.69%$2.91$2.7126,845 shs$23.98 million05/13/2024$2.89$2.88-0.35%$2.90$2.7927,465 shs$23.82 million05/10/2024$2.87$2.89+0.70%$2.90$2.706,088 shs$23.91 million05/09/2024$2.85$2.87+0.70%$2.90$2.8528,143 shs$23.74 million05/08/2024$2.76$2.85+3.26%$2.90$2.7520,959 shs$23.58 million05/07/2024$2.77$2.76-0.36%$2.83$2.7210,214 shs$22.83 million05/06/2024$2.66$2.77+4.14%$2.84$2.5922,393 shs$22.91 million05/03/2024$2.78$2.66-4.30%$2.80$2.6315,346 shs$22.00 million05/02/2024$2.55$2.78+9.00%$2.87$2.4851,822 shs$22.99 million05/01/2024$2.49$2.55+2.41%$2.57$2.504,963 shs$21.09 million04/30/2024$2.53$2.49-1.39%$2.59$2.4218,088 shs$20.59 million04/29/2024$2.48$2.53+1.81%$2.56$2.3932,904 shs$20.88 million04/26/2024$2.44$2.48+1.64%$2.58$2.4117,569 shs$20.51 million04/25/2024$2.46$2.44-0.81%$2.46$2.3526,464 shs$20.18 million04/24/2024$2.46$2.46+0.20%$2.51$2.2940,509 shs$20.34 million04/23/2024$2.52$2.46-2.58%$2.55$2.4522,778 shs$20.31 million04/22/2024$2.50$2.52+0.80%$2.56$2.4962,917 shs$20.84 million04/19/2024$2.56$2.50-2.34%$2.55$2.4953,925 shs$20.68 million04/18/2024$2.59$2.56-1.16%$2.66$2.4936,682 shs$21.40 million04/17/2024$2.75$2.59-5.82%$2.74$2.5835,975 shs$21.39 million04/16/2024$2.53$2.75+8.70%$2.77$2.49170,761 shs$22.72 million04/15/2024$2.71$2.53-6.64%$2.64$2.52107,151 shs$20.90 million04/12/2024$3.00$2.71-9.67%$3.30$2.422.17 million shs$22.39 million04/11/2024$2.93$3.00+2.39%$3.00$2.86242,097 shs$24.78 million04/10/2024$2.88$2.93+1.74%$2.93$2.91359 shs$24.20 million04/09/2024$2.86$2.88+0.70%$2.92$2.88878 shs$23.79 million04/08/2024$2.90$2.86-1.38%$2.95$2.851,492 shs$23.62 millionTrump’s Gift Could Unleash $51 Billion in New Wealth (Ad)In January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.You just have to make this simple move before July 30, 2024.04/05/2024$2.94$2.90-1.36%$2.90$2.841,123 shs$23.95 million04/04/2024$2.94$2.94$2.94$2.842,894 shs$24.29 million04/03/2024$2.93$2.94+0.34%$2.99$2.822,681 shs$24.28 million04/02/2024$2.98$2.93-1.68%$2.93$2.853,595 shs$24.20 million04/01/2024$2.93$2.98+1.71%$2.99$2.853,009 shs$24.62 million03/29/2024$2.93$2.93$3.01$2.9320,318 shs$24.21 million03/28/2024$2.98$2.93-1.68%$3.01$2.9320,318 shs$24.20 million03/27/2024$3.04$2.98-1.97%$2.98$2.961,766 shs$24.62 million03/26/2024$3.02$3.04+0.71%$3.06$2.9611,395 shs$25.11 million03/25/2024$3.06$3.02-1.36%$3.02$3.001,730 shs$24.93 million03/22/2024$3.05$3.06+0.33%$3.06$2.982,519 shs$25.28 million03/21/2024$3.07$3.05-0.65%$3.07$3.0515,927 shs$25.19 million03/20/2024$3.00$3.07+2.33%$3.07$2.957,300 shs$25.36 million03/19/2024$3.02$3.00-0.66%$3.07$2.9413,378 shs$24.78 million03/18/2024$2.98$3.02+1.34%$3.07$2.949,953 shs$24.95 million03/15/2024$2.95$2.98+1.02%$3.02$2.918,817 shs$24.62 million03/14/2024$3.01$2.95-1.99%$3.04$2.959,689 shs$24.37 million03/13/2024$3.01$3.01$3.03$3.0112,200 shs$24.86 million03/12/2024$2.95$3.01+2.03%$3.07$2.9336,781 shs$24.86 million03/11/2024$3.00$2.95-1.67%$2.99$2.921,518 shs$24.37 million03/08/2024$2.95$2.97+0.68%$3.07$2.917,281 shs$24.53 million03/07/2024$3.01$2.95-1.99%$3.01$2.9434,988 shs$24.37 million03/06/2024$3.02$3.01-0.33%$3.06$2.9024,409 shs$24.86 million03/05/2024$3.00$3.02+0.67%$3.05$2.965,193 shs$24.95 million03/04/2024$3.00$3.00$3.06$2.973,520 shs$24.78 million03/01/2024$2.91$3.00+3.09%$3.03$2.9010,002 shs$24.78 million Related Companies: Achilles Therapeutics Stock Price Chart DURECT Stock Price Chart Alpha Teknova Stock Price Chart VolitionRx Stock Price Chart ARCA biopharma Stock Price Chart ImmuCell Stock Price Chart Aspira Women's Health Stock Price Chart Cardio Diagnostics Stock Price Chart Trinity Biotech Stock Price Chart Biomerica Stock Price Chart Receive OCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for OncoCyte and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:OCX) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWho are Nvidia’s New Silent Partners?Weiss Ratings[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaBill Gates is all about this tiny $2 stockTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoCyte Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.